In 400 people aged 7–25 with type 1 diabetes in Bangladesh and Tanzania, switching to insulin glargine did not change time in very low glucose (3·6% vs 3·4%) or time in range (40·5% vs 38·1%) at 6 months versus usual isophane or premixed insulin.
RCTn = 400
Luo et al. Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial